LS
FBT icon

Leelyn Smith’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Leelyn Smith’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461K Buy
+2,298
New +$475K 0.06% 120
2020
Q3 		– Sell
-1,814
Closed -$304K – 338
2020
Q2 		$304K Buy
+1,814
New +$285K 0.13% 98

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Leelyn Smith's FBT Position: Q1 2026 in Review

Leelyn Smith opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026: 2,298 shares worth $461K. The stake represents 0.06% of the portfolio and ranks #120 among its holdings. This is a return to the name: Leelyn Smith previously reported a position in FBT as recently as Q2 2020.

Leelyn Smith first reported a position in FBT in Q2 2020 and has held it in 2 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Leelyn Smith held 2,298 shares of First Trust NYSE Arca Biotechnology Index Fund worth $461K as of Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Leelyn Smith position in Q1 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.06% of Leelyn Smith's portfolio in Q1 2026, its #120 holding.
  • Leelyn Smith first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and has held it in 2 quarters since.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Leelyn Smith's 13F filing for Q1 2026, filed 27 Apr 2026.